A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the effects of treatment with Seasonique an
extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the
typical hormone-free interval. Patients will receive 13 weeks of treatment with the option to
extend blinded therapy for an additional 13 weeks. The overall study duration will be 6-9
months. Patients will be required to record menstrual pain in a daily diary.
Phase:
Phase 2
Details
Lead Sponsor:
Duramed Research
Treatments:
Contraceptive Agents Contraceptives, Oral Ethinyl estradiol, levonorgestrel drug combination Levonorgestrel